GlassScriptPhysician profile
Bernard J Zaragoza
NPI 1093717944
$6,053.85
in general payments reported to CMS, 2019-2025
6 companies · $809 in 2025
The $809 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2021: $3,688 · 2022: $683 · 2023: $374 · 2024: $401 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,237 · Education: $208 · Travel and Lodging: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,237.29 |
| Education | $208.41 |
| Travel and Lodging | $137.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,316.30 | 2019-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $276.51 | 2022-2023 | |
| Davol INC. | $152.57 | 2021-2025 | Phasix Mesh |
| Tela Bio, INC. | $131.69 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Haemonetics Corporation | $123.66 | 2025 | Teg6s Hemostasis System |
| Kerecis Limited | $53.12 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Zaragoza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.